Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia LI Shlush, S Zandi, A Mitchell, WC Chen, JM Brandwein, V Gupta, ... Nature 506 (7488), 328-333, 2014 | 1614 | 2014 |
Prediction of acute myeloid leukaemia risk in healthy individuals S Abelson, G Collord, SWK Ng, O Weissbrod, N Mendelson Cohen, ... Nature 559 (7714), 400-404, 2018 | 802 | 2018 |
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns F Notta, M Chan-Seng-Yue, M Lemire, Y Li, GW Wilson, AA Connor, ... Nature 538 (7625), 378-382, 2016 | 567 | 2016 |
Tracing the origins of relapse in acute myeloid leukaemia to stem cells LI Shlush, A Mitchell, L Heisler, S Abelson, SWK Ng, A Trotman-Grant, ... Nature 547 (7661), 104-108, 2017 | 564 | 2017 |
Age-related clonal hematopoiesis LI Shlush Blood, The Journal of the American Society of Hematology 131 (5), 496-504, 2018 | 276 | 2018 |
Biological and clinical consequences of NPM1 mutations in AML EM Heath, SM Chan, MD Minden, T Murphy, LI Shlush, AD Schimmer Leukemia 31 (4), 798-807, 2017 | 209 | 2017 |
Potential antigenic cross-reactivity between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and dengue viruses Y Lustig, S Keler, R Kolodny, N Ben-Tal, D Atias-Varon, E Shlush, ... Clinical Infectious Diseases 73 (7), e2444-e2449, 2021 | 195 | 2021 |
Small molecules co-targeting CKIα and the transcriptional kinases CDK7/9 control AML in preclinical models W Minzel, A Venkatachalam, A Fink, E Hung, G Brachya, I Burstain, ... Cell 175 (1), 171-185. e25, 2018 | 126 | 2018 |
Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability LI Shlush, N Chapal-Ilani, R Adar, N Pery, Y Maruvka, A Spiro, R Shouval, ... Blood, The Journal of the American Society of Hematology 120 (3), 603-612, 2012 | 99 | 2012 |
High efficiency error suppression for accurate detection of low-frequency variants TT Wang, S Abelson, J Zou, T Li, Z Zhao, JE Dick, LI Shlush, TJ Pugh, ... Nucleic acids research 47 (15), e87-e87, 2019 | 87 | 2019 |
The Druze: a population genetic refugium of the Near East LI Shlush, DM Behar, G Yudkovsky, A Templeton, Y Hadid, F Basis, ... PLoS One 3 (5), e2105, 2008 | 84 | 2008 |
Colon stem cell and crypt dynamics exposed by cell lineage reconstruction Y Reizel, N Chapal-Ilani, R Adar, S Itzkovitz, J Elbaz, YE Maruvka, ... PLoS genetics 7 (7), e1002192, 2011 | 80 | 2011 |
Absence of HIV-associated nephropathy in Ethiopians DM Behar, LI Shlush, C Maor, M Lorber, K Skorecki American journal of kidney diseases 47 (1), 88-94, 2006 | 58 | 2006 |
Connections between clonal hematopoiesis, cardiovascular disease, and cancer: a review O Calvillo-Argüelles, S Jaiswal, LI Shlush, JJ Moslehi, A Schimmer, ... JAMA cardiology 4 (4), 380-387, 2019 | 56 | 2019 |
Telomere elongation followed by telomere length reduction, in leukocytes from divers exposed to intense oxidative stress–implications for tissue and organismal aging LI Shlush, KL Skorecki, S Itzkovitz, S Yehezkel, Y Segev, H Shachar, ... Mechanisms of ageing and development 132 (3), 123-130, 2011 | 51 | 2011 |
Quantitative digital in situ senescence-associated β-galactosidase assay LI Shlush, S Itzkovitz, A Cohen, A Rutenberg, R Berkovitz, S Yehezkel, ... BMC cell biology 12, 1-10, 2011 | 49 | 2011 |
Aging, clonal hematopoiesis and preleukemia: not just bad luck? LI Shlush, S Zandi, S Itzkovitz, AC Schuh International journal of hematology 102, 513-522, 2015 | 47 | 2015 |
Clonal evolution models of tumor heterogeneity LI Shlush, D Hershkovitz American Society of Clinical Oncology Educational Book 35 (1), e662-e665, 2015 | 46 | 2015 |
AML evolution from preleukemia to leukemia and relapse LI Shlush, A Mitchell Best Practice & Research Clinical Haematology 28 (2-3), 81-89, 2015 | 37 | 2015 |
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML AS Mer, EM Heath, SA Madani Tonekaboni, N Dogan-Artun, SK Nair, ... Nature Communications 12 (1), 1054, 2021 | 36 | 2021 |